{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:51:20Z","timestamp":1761947480683},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Estrogen exposures play a critical role in the development of endometrial cancer. Genetic variation in the estrogen metabolism UGT1A1 gene may modify the effect of estrogenic exposures on endometrial cancer risk. We tested this hypothesis in a population-based case-control study of 1,047 endometrial cancer cases and 1,035 controls who completed an in-person interview and were genotyped for the UGT1A1 polymorphisms rs2070959 (A\/G), rs887829 (G\/A), and rs8175347 (6\/7 TA repeats). Estrogen exposure-related factors evaluated include menstrual characteristics, oral contraceptive use, body mass index, waist-hip ratio, and soy food intake. Conditional logistic regression was used to calculate odds ratios and 95% confidence intervals. The homozygote variant genotype (G\/G) of the rs2070959 polymorphism was significantly associated with a reduced risk of endometrial cancer (odds ratio, 0.5; 95% confidence interval, 0.3-0.8). No significant associations between endometrial cancer risk and genotype were seen for the rs887829 and rs8175347 polymorphisms. Analysis of the joint effects of genotype and markers of estrogen exposure found the lowest risk of endometrial cancer among those with the homozygous variant genotype of the rs2070959 polymorphism and who were postmenopausal, had low body mass index, and had low soy food intake, although a test for multiplicative interaction was not significant. Taken together, these data suggest that the G\/G genotype (rs2070959) in the UGT1A1 gene may decrease the risk of endometrial cancer and that this effect is most evident among women with low levels of endogenous estrogen exposure or with low soy food intake. (Cancer Epidemiol Biomarkers Prev 2008;17(3):563\u201370)<\/jats:p>","DOI":"10.1158\/1055-9965.epi-07-0752","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T18:28:24Z","timestamp":1205864904000},"page":"563-570","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["<i>UGT1A1<\/i> Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk"],"prefix":"10.1158","volume":"17","author":[{"given":"Sandra L.","family":"Deming","sequence":"first","affiliation":[{"name":"1Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology, Shanghai Cancer Institute, Cancer Institute of Shanghai Jiao Tong University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyin","family":"Cai","sequence":"additional","affiliation":[{"name":"1Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixian","family":"Ruan","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology, Shanghai Cancer Institute, Cancer Institute of Shanghai Jiao Tong University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bing","family":"Xiang","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology, Shanghai Cancer Institute, Cancer Institute of Shanghai Jiao Tong University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[{"name":"1Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"2022060919105240800_BIB1","doi-asserted-by":"crossref","unstructured":"Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet\u20082005;365:1543\u201351.","DOI":"10.1016\/S0140-6736(05)66455-0"},{"key":"2022060919105240800_BIB2","doi-asserted-by":"crossref","unstructured":"Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol\u20081993;3:308\u201318.","DOI":"10.1016\/1047-2797(93)90035-3"},{"key":"2022060919105240800_BIB3","doi-asserted-by":"crossref","unstructured":"Cushing KL, Weiss NS, Voigt LF, et al. Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens. Obstet Gynecol\u20081998;91:35\u20139.","DOI":"10.1016\/S0029-7844(97)00577-2"},{"key":"2022060919105240800_BIB4","doi-asserted-by":"crossref","unstructured":"Weiderpass E, Adami HO, Baron JA, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst\u20081999;91:1131\u20137.","DOI":"10.1093\/jnci\/91.13.1131"},{"key":"2022060919105240800_BIB5","doi-asserted-by":"crossref","unstructured":"Parazzini F, La VC, Bocciolone L, et al. The epidemiology of endometrial cancer. Gynecol Oncol\u20081991;41:1\u201316.","DOI":"10.1016\/0090-8258(91)90246-2"},{"key":"2022060919105240800_BIB6","doi-asserted-by":"crossref","unstructured":"Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol\u20081995;85:304\u201313.","DOI":"10.1016\/0029-7844(94)00383-O"},{"key":"2022060919105240800_BIB7","unstructured":"Persson I, Adami H. Endometrial cancer. In: Adami I, Hunter D, Tricholpolos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002."},{"key":"2022060919105240800_BIB8","unstructured":"Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev\u20082002;11:1531\u201343."},{"key":"2022060919105240800_BIB9","doi-asserted-by":"crossref","unstructured":"Wagner JD, Anthony MS, Cline JM. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol\u20082001;44:843\u201352.","DOI":"10.1097\/00003081-200112000-00022"},{"key":"2022060919105240800_BIB10","doi-asserted-by":"crossref","unstructured":"Messina MJ, Persky V, Setchell KD, et al. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer\u20081994;21:113\u201331.","DOI":"10.1080\/01635589409514310"},{"key":"2022060919105240800_BIB11","unstructured":"Adlercreutz CH, Goldin BR, Gorbach SL, et al. Soybean phytoestrogen intake and cancer risk. J Nutr\u20081995;125:757\u201370S."},{"key":"2022060919105240800_BIB12","doi-asserted-by":"crossref","unstructured":"Baker ME. Endocrine activity of plant-derived compounds: an evolutionary perspective. Proc Soc Exp Biol Med\u20081995;208:131\u20138.","DOI":"10.3181\/00379727-208-43845"},{"key":"2022060919105240800_BIB13","unstructured":"Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr\u20081995;125:751\u20136S."},{"key":"2022060919105240800_BIB14","doi-asserted-by":"crossref","unstructured":"Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis\u20081998;19:1\u201327.","DOI":"10.1093\/carcin\/19.1.1"},{"key":"2022060919105240800_BIB15","doi-asserted-by":"crossref","unstructured":"Zhu BT, Fu JH, Xu S, et al. Different biochemical properties of nuclear and microsomal estrone-3-sulfatases: evidence for the presence of a nuclear isozyme. Biochem Biophys Res Commun\u20081998;246:45\u20139.","DOI":"10.1006\/bbrc.1998.8568"},{"key":"2022060919105240800_BIB16","unstructured":"Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res\u20082000;60:235\u20137."},{"key":"2022060919105240800_BIB17","unstructured":"Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res\u20081998;58:2269\u201377."},{"key":"2022060919105240800_BIB18","doi-asserted-by":"crossref","unstructured":"Mooberry SL. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat\u20082003;6:355\u201361.","DOI":"10.1016\/j.drup.2003.10.001"},{"key":"2022060919105240800_BIB19","unstructured":"Bailey LR, Roodi N, Verrier CS, et al. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res\u20081998;58:65\u201370."},{"key":"2022060919105240800_BIB20","doi-asserted-by":"crossref","unstructured":"Haiman CA, Hankinson SE, De VI, et al. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat\u20082003;77:27\u201336.","DOI":"10.1023\/A:1021112121782"},{"key":"2022060919105240800_BIB21","doi-asserted-by":"crossref","unstructured":"Siegelmann-Danieli N, Buetow KH. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br J Cancer\u20081999;79:456\u201363.","DOI":"10.1038\/sj.bjc.6690071"},{"key":"2022060919105240800_BIB22","unstructured":"Taioli E, Trachman J, Chen X, et al. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res\u20081995;55:3757\u20138."},{"key":"2022060919105240800_BIB23","doi-asserted-by":"crossref","unstructured":"Tao MH, Cai Q, Xu WH, et al. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and endometrial cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev\u20082006;15:2570\u20133.","DOI":"10.1158\/1055-9965.EPI-06-0498"},{"key":"2022060919105240800_BIB24","doi-asserted-by":"crossref","unstructured":"Doherty JA, Weiss NS, Freeman RJ, et al. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev\u20082005;14:357\u201366.","DOI":"10.1158\/1055-9965.EPI-04-0479"},{"key":"2022060919105240800_BIB25","doi-asserted-by":"crossref","unstructured":"Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol\u20082007;165:235\u201345.","DOI":"10.1093\/aje\/kwk015"},{"key":"2022060919105240800_BIB26","unstructured":"Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev\u20082001;10:217\u201322."},{"key":"2022060919105240800_BIB27","doi-asserted-by":"crossref","unstructured":"Millikan RC, Pittman GS, Tse CK, et al. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis\u20081998;19:1943\u20137.","DOI":"10.1093\/carcin\/19.11.1943"},{"key":"2022060919105240800_BIB28","unstructured":"Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev\u20081998;7:371\u20138."},{"key":"2022060919105240800_BIB29","doi-asserted-by":"crossref","unstructured":"Adegoke OJ, Shu XO, Gao YT, et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat\u20082004;85:239\u201345.","DOI":"10.1023\/B:BREA.0000025419.26423.b8"},{"key":"2022060919105240800_BIB30","unstructured":"Guillemette C, Millikan RC, Newman B, et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res\u20082000;60:950\u20136."},{"key":"2022060919105240800_BIB31","unstructured":"Guillemette C, De VI, Hankinson SE, et al. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev\u20082001;10:711\u20134."},{"key":"2022060919105240800_BIB32","doi-asserted-by":"crossref","unstructured":"Shatalova EG, Walther SE, Favorova OO, et al. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study. Breast Cancer Res\u20082005;7:R909\u201321.","DOI":"10.1186\/bcr1318"},{"key":"2022060919105240800_BIB33","doi-asserted-by":"crossref","unstructured":"Rebbeck TR, Troxel AB, Wang Y, et al. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst\u20082006;98:1311\u201320.","DOI":"10.1093\/jnci\/djj360"},{"key":"2022060919105240800_BIB34","doi-asserted-by":"crossref","unstructured":"Duguay Y, McGrath M, Lepine J, et al. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res\u20082004;64:1202\u20137.","DOI":"10.1158\/0008-5472.CAN-03-3295"},{"key":"2022060919105240800_BIB35","doi-asserted-by":"crossref","unstructured":"Xu WH, Dai Q, Xiang YB, et al. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol\u20082007;166:1420\u201330.","DOI":"10.1093\/aje\/kwm242"},{"key":"2022060919105240800_BIB36","doi-asserted-by":"crossref","unstructured":"Shu XO, Yang G, Jin F, et al. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur J Clin Nutr\u20082004;58:17\u201323.","DOI":"10.1038\/sj.ejcn.1601738"},{"key":"2022060919105240800_BIB37","doi-asserted-by":"crossref","unstructured":"Shatalova EG, Loginov VI, Braga EA, et al. Association of polymorphisms in SULT1A1 and UGT1A1 genes with breast cancer risk and phenotypes in Russian women. Mol Biol Mosk\u20082006;40:263\u201370.","DOI":"10.1134\/S0026893306020075"},{"key":"2022060919105240800_BIB38","unstructured":"Chinese Academy of Medical Sciences. Food composition tables. Beijing: People's Health Publishing House; 1991."},{"key":"2022060919105240800_BIB39","doi-asserted-by":"crossref","unstructured":"Franke AA, Hankin JH, Yu MC, et al. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem\u20081999;47:977\u201386.","DOI":"10.1021\/jf9808832"},{"key":"2022060919105240800_BIB40","doi-asserted-by":"crossref","unstructured":"Chen Z, Zheng W, Custer LJ, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer\u20081999;33:82\u20137.","DOI":"10.1080\/01635589909514752"},{"key":"2022060919105240800_BIB41","doi-asserted-by":"crossref","unstructured":"Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics\u20082005;21:263\u20135.","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"2022060919105240800_BIB42","doi-asserted-by":"crossref","unstructured":"Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol\u20082005;29:299\u2013312.","DOI":"10.1002\/gepi.20098"},{"key":"2022060919105240800_BIB43","unstructured":"The comprehensive R archive network. Available from: http:\/\/cran.r-project.org\/; 2006."},{"key":"2022060919105240800_BIB44","doi-asserted-by":"crossref","unstructured":"MacMahon B, Cole P, Brown JB, et al. Urine oestrogen profiles of Asian and North American women. Int J Cancer\u20081974;14:161\u20137.","DOI":"10.1002\/ijc.2910140204"},{"key":"2022060919105240800_BIB45","doi-asserted-by":"crossref","unstructured":"Sparks R, Ulrich CM, Bigler J, et al. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res\u20082004;6:R488\u201398.","DOI":"10.1186\/bcr818"},{"key":"2022060919105240800_BIB46","doi-asserted-by":"crossref","unstructured":"Shimizu H, Ross RK, Bernstein L, et al. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer\u20081990;62:451\u20133.","DOI":"10.1038\/bjc.1990.316"},{"key":"2022060919105240800_BIB47","doi-asserted-by":"crossref","unstructured":"Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr\u20082004;91:513\u201331.","DOI":"10.1079\/BJN20031075"},{"key":"2022060919105240800_BIB48","doi-asserted-by":"crossref","unstructured":"Cline JM, Hughes CL, Jr. Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treat Res\u20081998;94:107\u201334.","DOI":"10.1007\/978-1-4615-6189-7_7"},{"key":"2022060919105240800_BIB49","doi-asserted-by":"crossref","unstructured":"Burton JL, Wells M. The effect of phytoestrogens on the female genital tract. J Clin Pathol\u20082002;55:401\u20137.","DOI":"10.1136\/jcp.55.6.401"}],"container-title":["Cancer Epidemiology, Biomarkers &amp; Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/17\/3\/563\/1752460\/563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/17\/3\/563\/1752460\/563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T21:24:19Z","timestamp":1654809859000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cebp\/article\/17\/3\/563\/11030\/UGT1A1-Genetic-Polymorphisms-Endogenous-Estrogen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,18]]},"published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1055-9965.epi-07-0752","relation":{},"ISSN":["1055-9965","1538-7755"],"issn-type":[{"value":"1055-9965","type":"print"},{"value":"1538-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}